Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mydecine Innovations Group Inc (MYCO.CN)

Mydecine Innovations Group Inc (MYCO.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 74,871
  • Shares Outstanding, K 162,763
  • Annual Sales, $ 126 K
  • Annual Income, $ -3,508 K
  • 60-Month Beta 3.49
  • Price/Sales 1,088.43
  • Price/Cash Flow N/A
  • Price/Book 7.52
Trade MYCO.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.11
  • Most Recent Earnings -0.08 on 09/30/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.345 +15.94%
on 03/05/21
0.530 -24.53%
on 02/25/21
-0.100 (-20.00%)
since 02/24/21
3-Month
0.345 +15.94%
on 03/05/21
0.650 -38.46%
on 02/16/21
-0.070 (-14.89%)
since 12/24/20
52-Week
0.060 +566.67%
on 03/26/20
1.150 -65.22%
on 06/08/20
+0.330 (+471.43%)
since 03/24/20

Most Recent Stories

More News
NIH Director Touted Benefits of Psychedelics Including Psilocybin and MDMA

Psychedelics may be one step closer to decriminalization. All after the Director of the National ...

CLXPF : 1.7100 (-1.72%)
MNMD : 3.74 (-1.32%)
HAVN.CN : 0.660 (unch)
HAVLF : 0.5273 (+0.15%)
MYCOF : 0.2300 (-2.04%)
NMDBF : 0.1310 (-7.75%)
MYCO.CN : 0.285 (-1.72%)
NEON.CN : 0.160 (-8.57%)
Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products

USA News Group – Expanding way beyond just hunting for the perfect truffle, rising interest ...

VEGGF : 0.0610 (-4.98%)
CLXPF : 1.7100 (-1.72%)
TRUFF : 0.2525 (-12.90%)
TRIP.CN : 0.315 (-11.27%)
MYCOF : 0.2300 (-2.04%)
MYCO.CN : 0.285 (-1.72%)
DCNPF : 0.2171 (-1.36%)
PSYC.CN : 0.265 (-1.85%)
PLNT.CN : 0.075 (-6.25%)
PULL.CN : 0.240 (-9.43%)
Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products

, /PRNewswire/ --    -  Expanding way beyond just hunting for the perfect truffle, rising interest in the "" of mycology is creating gains across the , with a wave of new products to help us under...

PSYCF : 0.2142 (-3.99%)
PULL.CN : 0.240 (-9.43%)
PRXTF : 0.1926 (-10.42%)
CLXPF : 1.7100 (-1.72%)
TRUFF : 0.2525 (-12.90%)
TRIP.CN : 0.315 (-11.27%)
MYCOF : 0.2300 (-2.04%)
MYCO.CN : 0.285 (-1.72%)
PSYC.CN : 0.265 (-1.85%)
Psychedelics Becoming Valuable Alternatives to Conventional Mental Health Treatments

, /PRNewswire/ -- A pressing need for new treatment options for people suffering from mental health issues has opened the door to a new era of mental health innovation. Researchers, regulators, and consumers...

MYCO.CN : 0.285 (-1.72%)
MYCOF : 0.2300 (-2.04%)
PFE : 38.81 (-1.70%)
LLY : 218.55 (-1.65%)
CMPS : 36.34 (-0.63%)
JNJ : 161.98 (-1.96%)
Psychedelic Drugs Market Ballooning Quickly Due to Increasing Frequency of Mental Disorders

, /PRNewswire/ -- Psychedelic Medicines also called as hallucinogenics, are a group of substances including chemicals, such as LSD, and plants that are used in the treatment of various mental disorders...

MCUR.CN : 0.445 (+2.30%)
MCURF : 0.3624 (+3.54%)
LKYSF : 0.8300 (-1.31%)
NUMI.VN : 1.030 (-1.90%)
MYCOF : 0.2300 (-2.04%)
MYCO.CN : 0.285 (-1.72%)
CMPS : 36.34 (-0.63%)
MMEDF : 4.6900 (+33.24%)
More People Are Turning to Psychedelics to Treat Mental Health Issues

Psychedelic treatments could revolutionize the way millions are treated for mental health issues. So ...

PSYCF : 0.2142 (-3.99%)
MSSTF : 0.4190 (-0.62%)
MYCOF : 0.2300 (-2.04%)
NUMI.VN : 1.030 (-1.90%)
LKYSF : 0.8300 (-1.31%)
TRYP.CN : 0.570 (-6.56%)
MSET.CN : 0.510 (+2.00%)
MYCO.CN : 0.285 (-1.72%)
PSYC.CN : 0.265 (-1.85%)
Mydecine Innovations Group Provides Update on European Operations

Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), an emerging biopharma and life sciences company committed to the research, development, and acceptance of...

NVS : 93.01 (-1.21%)
MYCO.CN : 0.285 (-1.72%)
MYCOF : 0.2300 (-2.04%)
Mydecine Announces Change of Auditor

Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), announces that the board of directors of the Company has appointed MNP LLP, Chartered Professional Accountants...

MYCO.CN : 0.285 (-1.72%)
MYCOF : 0.2300 (-2.04%)
Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

*NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MYCO.CN : 0.285 (-1.72%)
MYCOF : 0.2300 (-2.04%)
The Race to Prove Psychedelics Can Help Resolve Mental Health Issues Has Just Begun

The psychedelics story is gaining momentum, as NeonMind Biosciences (CSE:NEON) (OTC:NMDBF), Lobe ...

LOBE.CN : 0.100 (-4.76%)
GTSIF : 0.0806 (-9.64%)
MYCOF : 0.2300 (-2.04%)
AIKI : 0.9687 (-4.09%)
SEEL : 3.02 (-4.43%)
NMDBF : 0.1310 (-7.75%)
MYCO.CN : 0.285 (-1.72%)
NEON.CN : 0.160 (-8.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.487
2nd Resistance Point 0.463
1st Resistance Point 0.432
Last Price 0.285
1st Support Level 0.377
2nd Support Level 0.353
3rd Support Level 0.322

See More

52-Week High 1.150
Fibonacci 61.8% 0.734
Fibonacci 50% 0.605
Fibonacci 38.2% 0.476
Last Price 0.285
52-Week Low 0.060

See More

Business Summary

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses:...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar